Literature DB >> 12411395

Smad2 mediates transforming growth factor-beta induction of endothelial nitric oxide synthase expression.

Marta Saura1, Carlos Zaragoza, Wangsen Cao, Clare Bao, Manuel Rodríguez-Puyol, Diego Rodríguez-Puyol, Charles J Lowenstein.   

Abstract

Transforming growth factor-beta (TGF-beta) increases expression of endothelial nitric oxide synthase (eNOS), although the precise mechanism by which it does so is unclear. We report that Smad2, a transcription factor activated by TGF-beta, mediates TGF-beta induction of eNOS in endothelial cells. TGF-beta induces Smad2 translocation from cytoplasm to nucleus, where it directly interacts with a specific region of the eNOS promoter. Overexpression of Smad2 increases basal levels of eNOS, and further increases TGF-beta stimulation of eNOS expression. Ectopic expression of Smurf, an antagonizer of Smad2, decreases Smad2 expression and blocks TGF-beta induction of eNOS. Because Smad2 can interact with a variety of transcription factors, coactivators, and corepressors, Smad2 may thus act as an integrator of multiple signals in the regulation of eNOS expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411395     DOI: 10.1161/01.res.0000040397.23817.e5

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  Long-term treatment with TGFbeta1 impairs mechanotransduction in bovine aortic endothelial cells.

Authors:  M Watanabe; M Oike; Y Ohta; Y Ito
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

2.  Sustained contraction and loss of NO production in TGFbeta1-treated endothelial cells.

Authors:  M Watanabe; M Oike; Y Ohta; H Nawata; Y Ito
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

Review 3.  The role of transforming growth factor β1 in the regulation of blood pressure.

Authors:  Kota Matsuki; Catherine K Hathaway; Marlon G Lawrence; Oliver Smithies; Masao Kakoki
Journal:  Curr Hypertens Rev       Date:  2014

4.  ZNF580 mediates eNOS expression and endothelial cell migration/proliferation via the TGF-β1/ALK5/Smad2 pathway.

Authors:  Yuyu Luo; Ying Zhao; Xiaodong Li; Juan Zhao; Wencheng Zhang
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

5.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.

Authors:  Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2013-03-24       Impact factor: 5.000

6.  Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.

Authors:  H H Clarice Yang; Jong Moo Kim; Elliott Chum; Cornelis van Breemen; Ada W Y Chung
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

Review 7.  Renal endothelial dysfunction in diabetic nephropathy.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014

Review 8.  Physiological role of ROCKs in the cardiovascular system.

Authors:  Kensuke Noma; Naotsugu Oyama; James K Liao
Journal:  Am J Physiol Cell Physiol       Date:  2006-03       Impact factor: 4.249

Review 9.  Endothelial NOS: perspective and recent developments.

Authors:  Victor Garcia; William C Sessa
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

10.  Loss of Transforming Growth Factor Beta Signaling in Aortic Smooth Muscle Cells Causes Endothelial Dysfunction and Aortic Hypercontractility.

Authors:  Jay Zhu; Stoyan Angelov; Ilkay Alp Yildirim; Hao Wei; Jie Hong Hu; Mark W Majesky; Frank V Brozovich; Francis Kim; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-15       Impact factor: 10.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.